Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Invasive candidiasis

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Testicular cancer

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Bipolar disorders

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Antiphospholipid syndrome

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Narcolepsy

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Diabetic retinopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Would you like to purchase a rodent with dermatophytes?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Invasive candidiasis is an important health-care-associated fungal infection that can be caused by several Candida spp.; the most common species is Candida albicans, but the prevalence of these organisms varies considerably depending on geographical location. The spectrum of disease of invasive candidiasis ranges from minimally symptomatic candidaemia to fulminant sepsis with an associated mortality exceeding 70%. Candida spp. are common commensal organisms in the skin and gut microbiota, and disruptions in the cutaneous and gastrointestinal barriers (for example, owing to gastrointestinal perforation) promote invasive disease. A deeper understanding of specific Candida spp. virulence factors, host immune response and host susceptibility at the genetic level has led to key insights into the development of early intervention strategies and vaccine candidates. The early diagnosis of invasive candidiasis is challenging but key to the effective management, and the development of rapid molecular diagnostics could improve the ability to intervene rapidly and potentially reduce mortality. First-line drugs, including echinocandins and azoles, are effective, but the emergence of antifungal resistance, especially among Candida glabrata, is a matter of concern and underscores the need to administer antifungal medications in a judicious manner, avoiding overuse when possible. A newly described pathogen, Candida auris, is an emerging multidrug-resistant organism that poses a global threat.

OriginalsprogEngelsk
TidsskriftNature reviews. Disease primers
Vol/bind4
Sider (fra-til)18026
ISSN2056-676X
DOI
StatusUdgivet - 11 maj 2018

ID: 56271350